WallStreetZen

AnalystsDavid Risinger
David Risinger's Stock Forecasts

Analyst Ranking
Top 28%
#972 out of 3466 analysts
Average Return
+7.36%
Win Rate
62%16 out of 26
Risk vs Reward
Poor
Good

David Risinger's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Horizon Therapeutics Public Ltd CoHZNP
+184.14%$31.85$90.50
2020-04-02 -
2021-04-01
Strong Buy
ELI LILLY & CoLLY
+74.18%$149.02$259.57
2020-09-03 -
2021-09-02
Strong Buy
Endo International plcENDP
+38.54%$6.85$4.21
2021-03-03 -
2021-10-19
Strong Sell
ELI LILLY & CoLLY
+32.38%$129.48$171.40
2019-12-18 -
2020-12-18
Strong Buy
ELI LILLY & CoLLY
+30.29%$142.18$185.24
2020-04-02 -
2021-04-01
Strong Buy

David Risinger's Stock Coverage

Name / Ticker# of RatingsRatingPrice TargetUpside/DownsideActionDate
Organon & CoOGN
1Hold$33.00-5.88%Initiates Coverage On
4 months ago
Bristol Myers Squibb CoBMY
2Hold$62.00+7.66%Downgrades
6 months ago
Jazz Pharmaceuticals plcJAZZ
3Hold$176.00+22.22%Maintains
7 months ago
Horizon Therapeutics Public Ltd CoHZNP
2Strong Buy$103.00-8.75%Reinstates
7 months ago
Viatris IncVTRS
1Hold$16.00+17.91%Maintains
7 months ago
PERRIGO Co plcPRGO
5Hold$45.00-1.42%Maintains
8 months ago
Endo International plcENDP
2Strong Sell$7.00+66.27%Maintains
8 months ago
Bausch Health Companies IncBHC
1Hold$35.00+22.89%Maintains
8 months ago
ELI LILLY & CoLLY
7Strong Buy$217.00-10.45%Maintains
9 months ago
AbbVie IncABBV
1Strong Buy$116.00+7.96%Maintains
9 months ago
Elanco Animal Health IncELAN
2Strong Buy$31.00N/AUpgrades
a year ago
Pfizer IncPFE
5Hold$42.00N/AMaintains
a year ago
Royalty Pharma plcRPRX
1Hold$51.00N/AInitiates Coverage On
a year ago
Zoetis IncZTS
2Hold$125.00N/AMaintains
2 years ago
Teva Pharmaceutical Industries LtdTEVA
7Strong Sell$8.00N/AMaintains
2 years ago
Merck & Co IncMRK
6Strong Buy$89.00N/AMaintains
2 years ago
Alkermes plcALKS
1Hold$16.00N/AMaintains
2 years ago
Allergan plcAGN
6Hold$156.00N/ADowngrades
3 years ago
Amneal Pharmaceuticals IncAMRX
1Hold$18.00N/ADowngrades
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.